Trestle Biotherapeutics

Trestle Biotherapeutics YC Application

Winter 2021Active

Trestle Biotherapeutics went through Y Combinator in the Winter 2021 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Winter 2021
Industry
HealthcareIndustrial Bio
Team size
2
Status
Active
Launched
2021

Founders

  • Ben Shepherd
    Ben ShepherdFounder
  • Alice Chen
    Alice ChenFounder

What Trestle Biotherapeutics does

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

Trestle Biotherapeutics's YC application, reconstructed

Y Combinator application

Trestle Biotherapeutics, Winter 2021 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Trestle Biotherapeutics

Describe what your company does in 50 characters or less.

Bioengineered kidneys for kidney failure

What is your company going to make? Please describe your product and what it does or will do.

We are building an implantable tissue that supplements kidney function for patients with end stage renal disease. Once implanted, it reduces or eliminates their need for dialysis and delays the time until transplantation is necessary.

Where do you live now, and where would the company be based after YC?

We currently live in San Diego, CA. After YC, we plan to keep the company based here to maintain close ties to our research partners and clinical collaborators.

Explain your decision regarding location.

San Diego is a biotech hub with strong academic and clinical resources. Being here lets us work closely with surgeons and researchers to develop an implantable kidney tissue tailored for patients.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real Trestle Biotherapeutics YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Trestle Biotherapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Trestle Biotherapeutics would present itself to YC, not the text they submitted.

What YC batch was Trestle Biotherapeutics in?

Trestle Biotherapeutics was part of the Y Combinator Winter 2021 batch.

Who founded Trestle Biotherapeutics?

Trestle Biotherapeutics was founded by Ben Shepherd, Alice Chen.

What does Trestle Biotherapeutics do?

Bioengineered kidneys for patients with kidney failure

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Trestle Biotherapeutics's application, and every other YC batch, is in YC Insights.

More YC startups like Trestle Biotherapeutics